Liaoning Port (02880): Xu Song resigns as non-executive director.

17:53 07/09/2023

Liaoning Port (02880) has announced that Mr. Xu Song has resigned as a non-executive director effective from September 6, 2023, due to a job change. Additionally, Dr. Xu will no longer serve as a member of the Board's Strategic Development Committee.

CSPC Pharma (01093) signs a strategic cooperation and licensing agreement with AstraZeneca for the development of innovative long-acting peptide drugs.

BLACK SESAME (02533): Liu Weihong has been transferred from an executive director to a non-executive director.

YEEBO (INT'L H)(00259): Suzhou Qingyue is expected to have a shareholder loss of about 74-100 million yuan in 2025.

CSPC Pharma (01093) signs a strategic cooperation and licensing agreement with AstraZeneca for the development of innovative long-acting peptide drugs.

BLACK SESAME (02533): Liu Weihong has been transferred from an executive director to a non-executive director.

YEEBO (INT'L H)(00259): Suzhou Qingyue is expected to have a shareholder loss of about 74-100 million yuan in 2025.